Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M158,178Revenue $M29,194Net Margin (%)51.5Altman Z-Score7.2
Enterprise Value $M162,188EPS $9.5Operating Margin %64.4Piotroski F-Score7
P/E(ttm)11.4Beneish M-Score-2.4Pre-tax Margin (%)62.9Higher ROA y-yY
Price/Book9.810-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales5.95-y EBITDA Growth Rate %27.2Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow9.5y-y EBITDA Growth Rate %103ROA % (ttm)43.7Higher Current Ratio y-yN
Dividend Yield %0.4PEG0.4ROE % (ttm)95.8Less Shares Outstanding y-yY
Payout Ratio %5.0Shares Outstanding M1,470ROIC % (ttm)86.1Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDJulian Robertson 2015-06-30 Add2.77%$97.72 - $122.21
($109.1)
$ 107.45-2%Add 72.52%399,411
GILDJohn Rogers 2015-06-30 Add0.28%$97.72 - $122.21
($109.1)
$ 107.45-2%Add 24.10%1,106,494
GILDNWQ Managers 2015-06-30 Add0.05%$97.72 - $122.21
($109.1)
$ 107.45-2%Add 28.38%145,200
GILDDavid Dreman 2015-06-30 Add0.04%$97.72 - $122.21
($109.1)
$ 107.45-2%Add 70.70%9,525
GILDJoel Greenblatt 2015-06-30 Reduce-0.03%$97.72 - $122.21
($109.1)
$ 107.45-2%Reduce 3.58%1,068,128
GILDKen Fisher 2015-06-30 Add$97.72 - $122.21
($109.1)
$ 107.45-2%Add 0.26%791,630
GILDRonald Muhlenkamp 2015-06-30 Reduce$97.72 - $122.21
($109.1)
$ 107.45-2%Reduce 0.05%218,620
GILDMario Gabelli 2015-06-30 Reduce$97.72 - $122.21
($109.1)
$ 107.45-2%Reduce 11.21%43,925
GILDJulian Robertson 2015-03-31 Reduce-5.61%$94.91 - $107.18
($101.54)
$ 107.456%Reduce 56.64%231,511
GILDLeon Cooperman 2015-03-31 Sold Out -0.96%$94.91 - $107.18
($101.54)
$ 107.456%Sold Out0
GILDFirst Eagle Investment 2015-03-31 Reduce-0.3%$94.91 - $107.18
($101.54)
$ 107.456%Reduce 99.97%400
GILDNWQ Managers 2015-03-31 Buy 0.14%$94.91 - $107.18
($101.54)
$ 107.456%New holding113,100
GILDJohn Rogers 2015-03-31 Add0.1%$94.91 - $107.18
($101.54)
$ 107.456%Add 11.07%891,645
GILDJoel Greenblatt 2015-03-31 Add0.07%$94.91 - $107.18
($101.54)
$ 107.456%Add 9.73%1,107,732
GILDDavid Dreman 2015-03-31 Buy 0.05%$94.91 - $107.18
($101.54)
$ 107.456%New holding5,580
GILDKen Fisher 2015-03-31 Add$94.91 - $107.18
($101.54)
$ 107.456%Add 2.35%789,615
GILDMario Gabelli 2015-03-31 Add$94.91 - $107.18
($101.54)
$ 107.456%Add 16.13%49,470
GILDRonald Muhlenkamp 2015-03-31 Reduce$94.91 - $107.18
($101.54)
$ 107.456%Reduce 0.09%218,740
GILDDodge & Cox 2015-03-31 Reduce$94.91 - $107.18
($101.54)
$ 107.456%Reduce 5.76%4,250
GILDKen Heebner 2014-12-31 Sold Out -4.7%$89.45 - $114.22
($103.4)
$ 107.454%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MARTIN JOHN CChairman and CEO 2015-08-25Sell133,213$105.172.17view
BISCHOFBERGER NORBERT WEVP, R&D and CSO 2015-08-17Sell70,000$116.16-7.5view
MILLIGAN JOHN FPresident and COO 2015-08-07Sell100,000$113.94-5.7view
Carter Paul RutherfordEVP Commercial Ops 2015-08-03Sell5,000$119.18-9.84view
Alton Gregg HEVP, Corp & Med Affairs 2015-08-03Sell17,000$119.11-9.79view
MARTIN JOHN CChairman and CEO 2015-08-03Sell150,000$119.18-9.84view
Cogan John FrancisDirector 2015-08-03Sell15,000$120-10.46view
MILLIGAN JOHN FPresident and COO 2015-07-07Sell100,000$114.44-6.11view
BISCHOFBERGER NORBERT WEVP, R&D and CSO 2015-07-07Sell70,000$118.27-9.15view
Alton Gregg HEVP, Corp & Med Affairs 2015-07-01Sell17,000$116.73-7.95view

Quarterly/Annual Reports about GILD:

    News about GILD:

    Articles On GuruFocus.com
    MMM Aug 28 2015 
    12 Attractive Fast-Growing Dividend Growth Stocks for High Total Return Aug 27 2015 
    Positions Aug 23 2015 
    Positions Aug 23 2015 
    JNJ – Should It Be In Your Portfolio? Aug 19 2015 
    Weekly CFO Sells Highlight: Facebook, Public Storage, Gilead Sciences Aug 17 2015 
    John Buckingham Buys 10 New Stakes in Second Quarter Aug 14 2015 
    Ronald Muhlenkamp Makes Small Changes in Composition of His Top 10 Stakes Aug 06 2015 
    Apple, Gilead and Hibbett Display Both Growth and Value Jul 29 2015 
    shortlist Jul 19 2015 

    More From Other Websites
    27 Stocks to Buy After the Pullback Aug 28 2015
    More Bargain Hunting: Three Places to Find the Fattest Dividends Aug 28 2015
    Best way to play the market Aug 27 2015
    Biogen And Gilead Sciences Catch The Eye Of Short Sellers Aug 27 2015
    'We See Opportunity in Biogen, Gilead and Regeneron,' Morgan Stanley Says Aug 27 2015
    Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary... Aug 26 2015
    5:02 pm Gilead Sciences announces results from AMBITION study of Letairis and tadalafil in pulmonary... Aug 26 2015
    Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary... Aug 26 2015
    Celldex (CLDX) Shows Strength: Stock Adds 8.2% in Session Aug 26 2015
    Short Sellers Become More Focused in Major Biotechs Aug 26 2015
    4 Notable Stocks Still Green After Late Tuesday Sell-Off Aug 25 2015
    Nasdaq Slips into Correction: 4 Stocks Stand Tall Aug 25 2015
    Gilead Leads 4 Drugmakers In Top Sector Performers Aug 25 2015
    AMAG is a Hidden Biotech Gem That is Exploding Aug 25 2015
    Gilead: Waiting Is the Best Part Aug 25 2015
    The Zacks Analyst Blog Highlights: Gilead Sciences, DSW, Cardtronics and CECO Environmental Aug 25 2015
    Trading the historic market dip: 6 stocks to buy Aug 24 2015
    Winners since last correction Aug 24 2015
    Biotechs rally back Aug 24 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK